Chenxi Pan

Chenxi Pan

Auto-generated profile, based on publicly available information

Chenxi Pan

Department of Neurology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2023 in Neurobiology of Disease
Verified
Journal Article
Open access
JRJingru Ren
Jingru Ren
LYLei Yan
Lei Yan
HZHao Zhou
Hao Zhou
CPChenxi Pan
Chenxi Pan
CXChen Xue
Chen Xue
WLWeiguo Liu
Weiguo Liu
Presently, neurotransmitter deficits in GBA-related Parkinson's disease (GBA-PD) and relationships with cognitive impairment are poorly understood. A better understanding of neurotransmitter impairments in GBA-PD - particularly in the newly diagnosed drug-naïve phase - may support developing targeted intervention strategies. We aimed to investigate patterns of neurotransmitter deficits in GBA-PD and idiopathic PD (iPD) and cognitive performance correlations. We recruited 189 newly diagnosed PD patients for GBA sequencing. Voxel-wise gray matter volume (GMV) was evaluated in a subgroup of 17 GBA-PD, 100 iPD, and 32 age- and sex-matched healthy controls (HCs). The JuSpace toolbox covering various neurotransmitter maps helped assess whether the spatial patterns of GMV alterations in GBA-PD or iPD patients (relative to HCs) were associated with specific neurotransmitter systems. GBA-PD patients indicated widespread GM atrophy in the fronto-temporal-occipital region compared with HCs. GMV atrophy was spatially correlated in GBA-PD and iPD with serotonergic, dopaminergic, and acetylcholinergic pathway distributions (p < 0.05, false discovery rate corrected). Executive function and language in cognitive domains were also associated with the strength of GMV colocalization of serotonergic, dopaminergic, and acetylcholinergic circuits. Regional GM atrophy related to specific neurotransmitter deficits in de novo GBA-PD and iPD patients could provide new insights into pathophysiological processes, facilitating potential therapeutic targets to support PD management.

1 March 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
CPChenxi Pan
Chenxi Pan
NDNingxin Dong
Ningxin Dong
XYXiao Yuan
Xiao Yuan
RLRenRen Li
RenRen Li
JMJing Ma
Jing Ma
YLYunxia Li
Yunxia Li
Background: Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment (MCI). However, knowledge is limited about the relationship of NPS, clinical factors, and cognition in MCI. Methods: A total of 1099 dementia, 1323 MCI and 377 cognitively normal (CN) were selected from the Tongji Cohort Study of Aging. All participants underwent comprehensive clinical and neuropsychological assessment. NPS were evaluated by the Neuropsychiatric Inventory Questionnaire (NPI-Q). Logistic regression analyses were conducted to investigate the relationship between clinical factors, cognition and NPS. Results: The NPS presented in 56.39% of MCI participants, and the NPI-Q scores of MCI was intermediate between CN and dementia. The most common NPS in MCI were depression (30.76%), anxiety (25.09%), apathy (19.43%), and irritability (12.02%). MCI patients with NPS showed worse performance in global, memory, language, and attention than those without NPS. Additionally, Logistic regression analyses revealed that MCI patients with ischemic heart disease (OR = 1.41; 95%CI 1.050–1.897; P = 0.022) were more likely to have NPS, but MCI patients with increased memory domain Z score (OR = 0.847, 95%CI = 0.720–0.996, p = 0.044), and language domain Z score (OR = 0.801, 95%CI = 0.682–0.941, p = 0.007) were less likely to have NPS. Conclusions: Neuropsychiatric symptoms occur commonly in MCI participants, and are mainly related to defect of language and memory function. A better understanding of the relationship between specific cognition and NPS may alert clinicians to pay close attention to the NPS in MCI patient, which may need early intervention.

25 June 2026 in International Psychogeriatrics
Verified
Journal Article
Open access
CPChenxi Pan
Chenxi Pan
JMJing Ma
Jing Ma
XYXiao Yuan
Xiao Yuan
RLRenren Li
Renren Li
XZXiaoran Zheng
Xiaoran Zheng
YLYunxia Li
Yunxia Li
The amygdala is known to exhibit early signs of Alzheimer's disease (AD) pathology. However, it remains unclear whether atrophy in its specific subregions contributes to the transition from mild cognitive impairment (MCI) with neuropsychiatric symptoms (NPS) to dementia. We recruited 376 participants at baseline: 130 MCI with NPS (MCI+NPS), 154 MCI without NPS (MCI-NPS), and 92 cognitively unimpaired (CU) individuals. Upon clinical follow-up, the MCI cohort was classified into 17 converters who progressed to dementia (MCI-c) and 96 non-converters who remained stable (MCI-nc). All participants underwent baseline and follow-up neuropsychological evaluations and multimodal magnetic resonance imaging (MRI). From the MRI data, we extracted volumes of amygdala subregions and used partial Spearman's correlations to assess their associations with NPS and cognitive alterations. Compared to the CU group, the MCI + NPS group exhibited more extensive bilateral amygdala atrophy, involving all subregions, whereas the MCI-NPS group showed atrophy confined to the bilateral centromedial (CeM) amygdala. Furthermore, relative to the MCI-nc group, the MCI-c group exhibited greater annual volume loss in the bilateral amygdalae and their subregions, except for the right CeM. The annual atrophy rate of the right basolateral (BLA) amygdala correlated with more severe affective (r = -0.274, p = 0.005) and hyperactivity symptoms (r = -0.343, p < 0.001). The annual atrophy rate of the left superficial (SUP) amygdala correlated with more severe affective symptoms (r = -0.273, p = 0.011). Progressive atrophy of the BLA and SUP is associated with NPS-related cognitive decline in MCI, suggesting a potential mechanistic role for these subregions and highlighting them as candidates for future targeted intervention.